Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The new compound may be a safer alternative to finasteride for prostate protection.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The inhibitor affects androgen metabolism but not ovarian function.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

HDAC inhibitors help brain cells grow and improve brain function.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Certain drugs that block specific enzymes can help treat prostate diseases.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Some dibenzo compounds might help treat cancer with fewer side effects.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.